Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 296.35
+5.54 (1.91%)
Sep 4, 2025, 4:10 PM AEST
Pro Medicus Market Cap
Pro Medicus has a market cap or net worth of 30.39 billion as of September 4, 2025. Its market cap has increased by 93.00% in one year.
Market Cap
30.39B
Enterprise Value
30.18B
Revenue
212.98M
Ranking
n/a
PE Ratio
264.13
Stock Price
296.35
Market Cap Chart
Since October 10, 2000, Pro Medicus's market cap has increased from 142.00M to 30.39B, an increase of 21,303.38%. That is a compound annual growth rate of 24.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 30.39B | 16.28% |
| Dec 31, 2024 | 26.14B | 161.11% |
| Dec 29, 2023 | 10.01B | 73.45% |
| Dec 30, 2022 | 5.77B | -11.46% |
| Dec 31, 2021 | 6.52B | 83.09% |
| Dec 31, 2020 | 3.56B | 53.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 100.90B |
| Cochlear | 19.36B |
| Sonic Healthcare | 11.24B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.79B |
| Mesoblast | 2.48B |
| Neuren Pharmaceuticals | 2.40B |